In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Shaping the future
An article discussing how the pandemic spread caused disruption but also a rapid deployment of solutions to ensure continuity in clinical trials and preserve and build resilience into ongoing research programmes.
-
Patient involvement in medical publications
Michael Pellegrino, SVP of Global Medical Communications, outlines research on patient involvement in the journal review process.
-
Moderna is designing a new version of its COVID-19 shot to fight the variant first found in South Africa
ICON’s David Morse, VP, Global Regulatory Affairs Consulting Services talks to Business Insider on regulatory pathways for development of new vaccines and vaccine boosters to address emerging COVID-19 variants.
-
News travels fast - The evolution and revolution within medical communications
Michael Pellegrino, SVP of Global Medical Communications weighs in on how industry has increasingly recognised the benefits of different communications for specific purposes and audiences.
-
Testing transmission in the community
ICON’s Dr. Andrew Garrett, Executive Vice President Scientific Operations, talks to Politico on clinical trials to test COVID-19 transmission in the community
-
2021: The year of decentralisation in drug development
An article discussing the challenges caused by the pandemic and how the environment has had to rely on technology, thus changing the traditional landscape of clinical research.
-
ICON supports Pfizer and BioNTech on the investigational COVID-19 vaccine trial
An article explaining how ICON was involved from the very first steps of the trial supporting Pfizer‘s and BioNTech’s implementation of a strategic plan and framework for the monitoring of the trial.
-
Irish pharma group ICON carried out trial of Pfizer-BioNTech vaccine
The Irish Times discusses how ICON carried out the Pfizer-BioNTech vaccine trials.
-
Vaccine trials were run to the highest regulatory standards
Dr. Nuala Murphy, President of Clinical Research Services, discusses how ICON carried out the COVID-19 vaccine trials.
-
BARDA wants you
An article from Pharma Manufacturing which explains why BARDA is looking to recruit more partners in Pharma, featuring commentary from ICON's Dr. James Cummings.
